Literature DB >> 12493840

Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats.

Margherita Ruoppolo1, Stefania Orrù, Simona Francese, Ivana Caputo, Carla Esposito.   

Abstract

The accumulation of abnormal polyglutamine-containing protein aggregates within the cytosol and nuclei of affected neurons is a hallmark of the progressive neurodegenerative disorders caused by an elongated (CAG)(n) repeat in the genome. The polyglutamine domains are excellent substrates for the enzyme transglutaminase type 2 (tissue), resulting in the formation of cross-links with polypeptides containing lysyl groups. Enzymatic activity toward the Q(n) domains increases greatly upon lengthening of such Q(n) stretches (n > 40). Among the possible amine donors, the glycolytic enzyme glyceraldehyde-3-phosphate-dehydrogenase was shown to tightly bind several proteins involved in polyglutamine expansion diseases. Recently, the authors have shown that K191, K268, and K331, out of the 26 lysines present in glyceraldehyde-3-phosphate-dehydrogenase, are the reactive amine-donor sites forming cross-links with substance P, which bears the simplest Q(n) domain (n = 2). The present study reports that synthetic peptides of both pathological and nonpathological length (n = 43 and 17, respectively) form cross-links with the same K residues located in the C-terminal region of glyceraldehyde-3-phosphate-dehydrogenase. In addition, it is shown that extra K residues present in the C termini of glyceraldehyde-3-phosphate-dehydrogenase are susceptible to cross-linking in the presence of transglutaminase. The present results indicate a possible modulating effect of Q(n) stretches on tissue transglutaminase substrate specificity and mechanism of recognition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12493840      PMCID: PMC2312406          DOI: 10.1110/ps.0216103

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  44 in total

1.  Solubilization and disaggregation of polyglutamine peptides.

Authors:  S Chen; R Wetzel
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

Review 2.  Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.

Authors:  D Aeschlimann; V Thomazy
Journal:  Connect Tissue Res       Date:  2000       Impact factor: 3.417

Review 3.  Transcriptional dysregulation in Huntington's disease.

Authors:  J H Cha
Journal:  Trends Neurosci       Date:  2000-09       Impact factor: 13.837

4.  N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.

Authors:  T M Jeitner; M B Bogdanov; W R Matson; Y Daikhin; M Yudkoff; J E Folk; L Steinman; S E Browne; M F Beal; J P Blass; A J Cooper
Journal:  J Neurochem       Date:  2001-12       Impact factor: 5.372

5.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.

Authors:  S Chen; V Berthelier; W Yang; R Wetzel
Journal:  J Mol Biol       Date:  2001-08-03       Impact factor: 5.469

6.  Tissue transglutaminase is increased in Huntington's disease brain.

Authors:  M Lesort; W Chun; G V Johnson; R J Ferrante
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

7.  Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z.

Authors:  P Grenard; M K Bates; D Aeschlimann
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

Review 8.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

9.  Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.

Authors:  A J Cooper; K R Sheu; J R Burke; O Onodera; W J Strittmatter; A D Roses; J P Blass
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

10.  Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease.

Authors:  B A Citron; K S SantaCruz; P J Davies; B W Festoff
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

View more
  3 in total

Review 1.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

2.  The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction.

Authors:  Jee-Yeon Lee; Yeon-Ju Lee; Hye-Yoon Jeon; Eun-Taek Han; Won Sun Park; Seok-Ho Hong; Young-Myeong Kim; Kwon-Soo Ha
Journal:  FASEB J       Date:  2019-08-28       Impact factor: 5.191

3.  Occurrence of a multimeric high-molecular-weight glyceraldehyde-3-phosphate dehydrogenase in human serum.

Authors:  Rani Kunjithapatham; Jean-Francois Geschwind; Lauren Devine; Tatiana N Boronina; Robert N O'Meally; Robert N Cole; Michael S Torbenson; Shanmugasundaram Ganapathy-Kanniappan
Journal:  J Proteome Res       Date:  2015-03-18       Impact factor: 4.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.